fingolimod

美 　英

• 網(wǎng)絡芬戈莫德；芬格莫德；芬戈利德

例句

But "there are patients who do not like injections and do not tolerate them, and these patients may want to go onto" fingolimod, he said.

但是“有很多病人不喜歡注射給藥，甚至是不能容忍。這些病人可能會轉(zhuǎn)向fingolimod”。

Dr. Weiner wasn't involved in fingolimod's development but said he does consulting work for a number of drug companies, including Novartis.

Weiner博士并沒有參與fingolimod的研發(fā)，但是他說他為很制藥公司提供咨詢，包括諾華公司。

The FDA approved fingolimod as a first-line treatment for the most common form of MS, meaning patients can take it as their first treatment.

美國食品藥品監(jiān)督管理局批準fingolimod作為大多數(shù)多發(fā)性硬化癥的一線治療藥物，也就是說病人將使用該藥物作為首選藥物。

He added that other clinical trials are needed to demonstrate fingolimod's efficacy against drugs other than Avonex.

他還說還需要更多的臨床試驗去證明fingolimod比其他藥物如avonex更加有效。